Engineering Phototheranostic Nanoscale Metal-Organic Frameworks for Multimodal Imaging-Guided Cancer Therapy

被引:303
作者
Cai, Wen [1 ,2 ]
Gao, Haiyan [2 ]
Chu, Chengchao [2 ]
Wang, Xiaoyong [2 ]
Wang, Junqing [2 ]
Zhang, Pengfei [2 ]
Lin, Gan [2 ]
Li, Wengang [2 ]
Liu, Gang [2 ]
Chen, Xiaoyuan [3 ]
机构
[1] Xi An Jiao Tong Univ, Hlth Sci Ctr, Sch Basic Med Sci, Inst Med Engn, Xian 710061, Shaanxi, Peoples R China
[2] Xiamen Univ, Sch Publ Hlth, State Key Lab Mol Vaccinol & Mol Diagnost, Ctr Mol Imaging & Translat Med, Xiamen 361102, Fujian, Peoples R China
[3] NIBIB, LOMIN, NIH, Bethesda, MD 20892 USA
基金
中国国家自然科学基金;
关键词
metal-organic frameworks (MOFs); indocyanine green; theranostic; bioimaging; photothermal therapy; INDOCYANINE-GREEN; PHOTOTHERMAL THERAPY; DRUG-DELIVERY; MAGNETIC-RESONANCE; TARGETED DELIVERY; PD NANOSHEETS; NANOPARTICLES; NANOMATERIALS; FLUORESCENCE; MIL-100(FE);
D O I
10.1021/acsami.6b11579
中图分类号
TB3 [工程材料学];
学科分类号
0805 ; 080502 ;
摘要
Many photoresponsive dyes have been utilized as imaging and photodynamic/photothermal therapy agents. Indocyanine green (ICG) is the only near-infrared region (NIR) organic dye for clinical applications approved by the United States Food and Drug Administration; however, the clinical application of ICG is limited by its poor aqueous solubility, low cancer specificity, and low sensitivity in cancer theranostics. To overcome these issues, a multifunctional nanoplatform based on hyaluronic acid (HA) and ICG-engineered metal-organic framework MIL-100(Fe) nanoparticles (MOF@HA@ICG NPs) was successfully developed for imaging-guided, anticancer photothermal therapy (PTT). The synthesized NPs showed a high loading content of ICG (40%), strong NIR absorbance, and photostability. The in vitro and in vivo imaging showed that the MOF@HA@ICG NPs exhibited greater cellular uptake in CD44-positive MCF-7 cells and enhanced tumor accumulation in xenograft tumors due to their targeting capability, compared to MOF@ICG NPs (non-HA-targeted) and free ICG. The in vitro photothermal toxicity and in vivo PTT treatments demonstrated that MOF@HA@ICG NPs could effectively inhibit the growth of MCF-7 cells/xenograft tumors. These results suggest that MOF@HA@ICG NPs could be served as a new promising theranostic nanoplatform for improved anticancer PTT through cancer-specific and image-guided drug delivery.
引用
收藏
页码:2040 / 2051
页数:12
相关论文
共 63 条
[61]   Robust ICG Theranostic Nanoparticles for Folate Targeted Cancer Imaging and Highly Effective Photothermal Therapy [J].
Zheng, Mingbin ;
Zhao, Pengfei ;
Luo, Zhenyu ;
Gong, Ping ;
Zheng, Cuifang ;
Zhang, Pengfei ;
Yue, Caixia ;
Gao, Duyang ;
Ma, Yifan ;
Cai, Lintao .
ACS APPLIED MATERIALS & INTERFACES, 2014, 6 (09) :6709-6716
[62]   Enhanced Tumor Treatment Using Biofunctional Indocyanine Green-Containing Nanostructure by Intratumoral or Intravenous Injection [J].
Zheng, Xiaohui ;
Zhou, Feifan ;
Wu, Baoyan ;
Chen, Wei R. ;
Xing, Da .
MOLECULAR PHARMACEUTICS, 2012, 9 (03) :514-522
[63]   CuS Nanodots with Ultrahigh Efficient Renal Clearance for Positron Emission Tomography Imaging and Image-Guided Photothermal Therapy [J].
Zhou, Min ;
Li, Junjie ;
Liang, Su ;
Sood, Anil K. ;
Liang, Dong ;
Li, Chun .
ACS NANO, 2015, 9 (07) :7085-7096